Gene: ARHGAP39
Official Full Name: Rho GTPase activating protein 39provided by HGNC
Gene Summary: Predicted to enable GTPase activator activity. Involved in postsynapse organization. Is active in glutamatergic synapse. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO25953 | ARHGAP39 Knockout cell line (HeLa) | Human | ARHGAP39 | 1:3~1:6 | Negative | Online Inquiry |
KO25954 | ARHGAP39 Knockout cell line (HCT 116) | Human | ARHGAP39 | 1:2~1:4 | Negative | Online Inquiry |
KO25955 | ARHGAP39 Knockout cell line (HEK293) | Human | ARHGAP39 | 1:3~1:6 | Negative | Online Inquiry |
KO25956 | ARHGAP39 Knockout cell line (A549) | Human | ARHGAP39 | 1:3~1:4 | Negative | Online Inquiry |
ARHGAP39 Gene Knockout Cell Lines are genetically engineered cellular models designed to investigate the functions and interactions of the ARHGAP39 gene, a member of the Rho GTPase-activating protein family that plays a crucial role in the regulation of actin cytoskeleton dynamics. The ARHGAP39 protein is known to modulate key signaling pathways that influence various cellular processes, including cell migration, proliferation, and differentiation. By utilizing CRISPR-Cas9 technology, these knockout cell lines effectively disable the ARHGAP39 gene, allowing researchers to directly observe the resulting phenotypic and molecular changes.
The primary function of ARHGAP39 is to act as a negative regulator of Rho GTPases, which are pivotal in controlling actin polymerization and, consequently, cellular motility. By examining ARHGAP39 knockout cell lines, scientists can gain invaluable insights into the mechanistic pathways that underlie various biological processes and disease states such as cancer metastasis and neurodegenerative disorders. These models serve as indispensable tools in pharmacological testing, as they allow for the identification of new therapeutic targets by elucidating the role of ARHGAP39 in cellular signaling.
One significant advantage of ARHGAP39 knockout cell lines lies in their specificity and relevance. Unlike other models that may not accurately replicate the gene's absence, these lines offer a precise genetic background ideal for studying the direct effects of ARHGAP39 loss-of-function. Additionally, their ability to yield reproducible data across experiments enhances their value for basic research and clinical applications. This uniqueness positions ARHGAP39 knockout cell lines as a superior choice compared to general knockouts or overexpression systems, where results may be confounded by genetic variability.
For researchers and clinicians dedicated to understanding the intricate web of cell signaling and its impact on health and disease, ARHGAP39 Gene Knockout Cell Lines represent a powerful resource. They empower users to explore novel therapeutic avenues and streamline the drug development pipeline, ultimately contributing to advancements in precision medicine.
Our company specializes in providing high-quality genetic models and cell lines tailored for research needs, ensuring that our products meet rigorous scientific standards to support the groundbreaking work of our clients.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.